Comparative study of low dose of capecitabine versus standard dose in metastatic breast cancer: Efficacy and safety
By: Engy M Aboelnaga and Wafaa El-beshbishi
Language: English
Page range: 12 - 21
Submitted on: Jul 5, 2019
Accepted on: Nov 5, 2019
Published on: Aug 9, 2021
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2021 Engy M Aboelnaga, Wafaa El-beshbishi, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.